Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ) SHZ

0.59

+0.02(+3.51%)

Updated at June 26, 2025 03:04PM

Currency In CNY

Valuation

Market Cap877.1M
Enterprise Value618.3M
P/E Ratio-5.71
PEG Ratio-0.06
Price/Sales Ratio7.17
Price/Book Ratio0.51
Enterprise/Revenue5.68
Enterprise/EBITDA-4.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-1.25
Operating Margin-1.34

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.09

Income Statement

Revenue66.48M
Revenue/Share0.08
Gross Profit42.71M
EBITDA-28.39M
Net Income-41.44M
Diluted EPS-0.1

Balance Sheet

Total Cash270.29M
Total Cash/Share0.68
Total Debt1.81M
Total Debt/Equity0
Current Ratio7.94
Book Value Per Share1.21

Price History

52-Week Change-72.56
52-Week High3.12
52-Week Low0.56
Moving Average 50 Days0.98
Moving Average 200 Days1.71

Statistics

Average Volume6.62M
Shares Outstanding400.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor2:1
Last Split DateMay 18, 2016